Can Biogen beat the memory thief?

http://for.tn/1QkEiAQ

Of the leading causes of death, Alzheimer’s Disease is the only one for which there is no way to prevent it, cure it, or slow its progression. A Boston-area biotech may be closer than ever to solving the puzzle.

Above illustration by Sinelab

Even before Jeffrey Sevigny stepped to the podium, it was clear that something momentous had occurred in the world of Alzheimer’s research. Before Biogen’s senior medical director for clinical development could click on the first slide of his PowerPoint deck, tens of billions of biotech investment dollars had already been wagered on what his presentation would say.